Table 1. Summary of the main suggested mechanisms of cardiotoxicity by group of drugs.
Anthracyclines | DNA double-strand break (topoisomerase IIB) |
Oxidative stress (reactive oxygen species) | |
Cell membrane hyperpermeability (lipid peroxidation) | |
Ultrastructural changes | |
Cytoplasmic vacuolization | |
Apoptosis | |
Trastuzumab | Interruption of HER-2/ERBB2 receptor signaling – Neuregulin 1 |
Inhibits cell repair | |
Cell dysfunction | |
Cisplatin Cyclophosphamide |
Direct endothelial injury |
Platelet activation and aggregation | |
Coronary thrombosis | |
5-Fluorouracil |
Acts on the molecular signaling pathway that regulates smooth muscle tone |
Vasospasm – vasoconstriction | |
Vascular endothelial growth factor (VEGF) inhibitors |
Inhibit nitric oxide synthase activity |
Increase endothelin production | |
Inhibit rho-kinase activation | |
Vasospasm | |
Protease inhibitors | Interference with the degradation of dysfunctional proteins |
Functional changes in the myocyte | |
Immune checkpoint inhibitors | Increased T-cell activity |
Autoimmune activity in the heart muscle |